Gene · 6278
Papers2,053
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,053
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Nomogram Based on S100A7 and Clinicopathological Characteristics to Predict the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Study. | Ther Clin Risk Manag | 2025 | 40066058 | PubTator, text mining | PubMed |
| Exosomal integrin alpha 3 promotes epithelial ovarian cancer cell migration via the S100A7/p-ERK signaling pathway. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40055916 | PubTator, text mining | PubMed |
| Erratum for the "S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis" by Zhiliang Lu et al. | Clin Transl Med | 2025 | 39901337 | PubTator, text mining | PubMed |
| Renal tubular S100A7a impairs fatty acid oxidation and exacerbates renal fibrosis via both intracellular and extracellular pathway. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39778778 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation-related genes associated with prognosis, tumor microenvironment characteristics, and tumor cell features in bladder cancer. | Clin Transl Oncol | 2025 | 39269596 | PubTator, text mining | PubMed |
| Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1. | J Invest Dermatol | 2025 | 39004117 | PubTator, text mining | PubMed |
| Comparative Analysis of Digital Transcriptomics Between Pre- and Post-Treatment Samples of Patients with Locally Advanced Cervical Cancer: A Preliminary Study. | Curr Issues Mol Biol | 2024 | 39590310 | PubTator, text mining | PubMed |
| S100A7 orchestrates neutrophil chemotaxis and drives neutrophil extracellular traps (NETs) formation to facilitate lymph node metastasis in cervical cancer patients. | Cancer Lett | 2024 | 39384116 | PubTator, text mining | PubMed |
| Cold Plasma Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice. | Skin Res Technol | 2024 | 39349353 | PubTator, text mining | PubMed |
| Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris. | Postepy Dermatol Alergol | 2024 | 39290897 | PubTator, text mining | PubMed |
| Rutin alleviates psoriasis-related inflammation in keratinocytes by regulating the JAK2/STAT3 signaling. | Skin Res Technol | 2024 | 39167035 | PubTator, text mining | PubMed |
| Prognostic Value of S100 Family mRNA Expression in Hepatocellular Carcinoma. | Turk J Gastroenterol | 2024 | 39128058 | PubTator, text mining | PubMed |
| Key genes and immune infiltration patterns and the clinical implications in psoriasis patients. | Skin Res Technol | 2024 | 39120060 | PubTator, text mining | PubMed |
| Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion. | Virol J | 2024 | 39095779 | PubTator, text mining | PubMed |
| Artificial Intelligence Applications in Oral Cancer and Oral Dysplasia. | Tissue Eng Part A | 2024 | 39041628 | PubTator, text mining | PubMed |
| LncRNA lnc-SPRR2G-2 contributes to keratinocyte hyperproliferation and inflammation in psoriasis by activating the STAT3 pathway and downregulating KHSRP. | Mol Cell Probes | 2024 | 38942130 | PubTator, text mining | PubMed |
| GLI Transcriptional Targets S100A7 and KRT16 Show Upregulated Expression Patterns in Epidermis Overlying the Tumor Mass in Melanoma Samples. | Int J Mol Sci | 2024 | 38892279 | PubTator, text mining | PubMed |
| Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia. | J Oral Maxillofac Pathol | 2024 | 38800445 | PubTator, text mining | PubMed |
| S100 proteins: a new frontier in fibromyalgia research. | Mol Brain | 2024 | 38797848 | PubTator, text mining | PubMed |
| IL-17: a novel player in the pathogenesis of vulvar lichen sclerosus. | Postepy Dermatol Alergol | 2024 | 38784924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6278/papers?page=4